Form 4: Opko Health Sells GeneDx Holdings Corp. Shares
SEC Form 4
Opko Health, a significant shareholder in GeneDx Holdings Corp., sold 36,118 shares of Class A Common Stock at an average price of $28.2412 on July 5, 2024.
Summary
- Opko Health, Inc. sold 36,118 shares of GeneDx Holdings Corp. Class A Common Stock on July 5, 2024.
- The shares were sold at a weighted average price of $28.2412.
- The sales occurred in multiple transactions with prices ranging from $28.00 to $28.75.
- Following the transaction, Opko Health beneficially owns 3,433,403 shares of GeneDx Holdings Corp.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a standard transaction. The sale itself doesn't indicate positive or negative outlook, but rather a change in holdings.
Industry Context
Form 4 filings are standard practice when significant shareholders or insiders of a company trade shares, providing transparency to the market.
Key Dates
| Date | Description |
|---|---|
| 07/05/2024 | Date of the transaction where Opko Health sold shares of GeneDx Holdings Corp. |
| 07/09/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.